Philippe Moris

Philippe Moris is an experienced professional currently serving as a Project Manager at BePharBel Manufacturing SA since February 2021 and as the Clinical Immunology Head at Osivax since March 2020. Additionally, Philippe Moris has been working as a consultant since February 2020. From August 1996 to January 2020, Philippe Moris held the position of Senior Principal Scientist at GSK. Philippe Moris holds a Master's degree in Economic & Social Sciences and a Master's degree in Biologie cellulaire et moléculaire, both from Université de Namur.